
Professional Education
 |
Articles/Materials |
- Pro-Argin™ Technology Mode Of Action
Learn how the Pro-Argin™ technology behind Colgate® Sensitive Pro-Relief™ works.
- Colgate® Sensitive Pro-Relief™ Study
Hamlin et al.
Colgate® Sensitive Pro-Relief™ with Pro-Argin™ Technology is clinically proven to provide immediate and lasting sensitivity relief after a single application.
- Colgate® Sensitive Pro-Relief™ Study
Schiff et al.
Colgate® Sensitive Pro-Relief™ with Pro-Argin™ Technology reduces dentine hypersensitvity, lasting four weeks, immediately after a single application as compared to a control.
- American Journal of Dentistry, Pro-Argin™ Special Issue
Introducing Pro-Argin™, a Breakthrough Technology Based upon Arginine and Calcium for In-Surgery Treatment of Dentin Hypersensitivity
- The Journal of Clinical Dentistry®, Pro-Argin™ Special Issue
Pro-Argin™ — a Breakthrough Technology Based Upon Arginine and Calcium — for the Everyday Relief of Dentin Hypersensitivity
- Pro-Argin Study Summary Ayad et al Toothpaste Efficacy
When used over a period of 8 weeks, the novel toothpaste containing arginine and MFP in a calcium carbonate base significantly reduced dentine hypersensitivity (p < 0.05) in response to both the tactile and air blast stimuli. Compared to the commercial toothpaste with 2% potassium ion and NaF, the arginine containing toothpaste was significantly (p < 0.05) more effective in reducing hypersensitivity scores after 2, 4, and 8 weeks of use (16.2%, 22.4%, and 21.4% for tactile stimuli; 16.2%, 29.2%, and 63.4% for air blast stimuli).
- Pro-Argin Study Summary Docimo et al Toothpaste Efficacy
When used over a period of 8 weeks, the novel toothpaste containing arginine and MFP in a calcium carbonate base significantly reduced dentine hypersensitivity (p < 0.05) in response to both the tactile and air blast stimuli. Compared to the commercial toothpaste with 2% potassium ion and NaF, the arginine containing toothpaste was significantly (p < 0.05) more effective in reducing hypersensitivity scores after 2, 4, and 8 weeks of use (37.0%, 30.0%, and 12.2% for tactile stimuli; 23.9%, 32.0%, and 29.3% for air blast stimuli).
 |
Videos |
Patient Education
 |
Images |
|
|